Current and Emerging Approaches to Acquired Resistance for ALK/ROS1 episode artwork

EPISODE · Oct 23, 2014 · 29 MIN

Current and Emerging Approaches to Acquired Resistance for ALK/ROS1

from GRACEcast · host cancerGRACE Meetings

Acquired Resistance Forum Video #9: Dr. Alice Shaw of Massachusetts General Hospital detailed for patients the so-called "next generation" ALK/ROS1 inhibitors, both those commercially available and those still in development.

Episode metadata supplied by the publisher feed · Published Oct 23, 2014

Embed this episode

NOW PLAYING

Current and Emerging Approaches to Acquired Resistance for ALK/ROS1

0:00 29:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 29 minutes long.

When was this GRACEcast episode published?

This episode was published on October 23, 2014.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!